US Patent Issued to CAELUS PHARMACEUTICALS on June 16 for "Fecal matter for preventing or treating intestinal microbiome aberrations in cesarean section-born infants" (Dutch Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,848, issued on June 16, was assigned to CAELUS PHARMACEUTICALS B.V. (Zegveld, Netherlands).

"Fecal matter for preventing or treating intestinal microbiome aberrations in cesarean section-born infants" was invented by Willem Meindert De Vos (Amsterdam) and Lucas Gerardus Willibrordus Sterkman (Heiloo, Netherlands).

According to the abstract* released by the U.S. Patent & Trademark Office: "A composition for use in the prevention or treatment of intestinal microbiota aberration in a Cesarean section- (CS-) born infant, wherein the use is particularly for one or more of reducing intestinal colonization of pathogenic microorganisms, increasing intestinal relative abundance of Bactero...